MXPA02002901A - Enzimas de ruta de enfocado lisosomal. - Google Patents
Enzimas de ruta de enfocado lisosomal.Info
- Publication number
- MXPA02002901A MXPA02002901A MXPA02002901A MXPA02002901A MXPA02002901A MX PA02002901 A MXPA02002901 A MX PA02002901A MX PA02002901 A MXPA02002901 A MX PA02002901A MX PA02002901 A MXPA02002901 A MX PA02002901A MX PA02002901 A MXPA02002901 A MX PA02002901A
- Authority
- MX
- Mexico
- Prior art keywords
- lysosomal targeting
- pathway enzymes
- targeting pathway
- methods
- enzyme
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title abstract 3
- 108090000790 Enzymes Proteins 0.000 title abstract 3
- 230000002132 lysosomal effect Effects 0.000 title abstract 2
- 230000037361 pathway Effects 0.000 title abstract 2
- 230000008685 targeting Effects 0.000 title abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1223—Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04045—N-Acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (3.1.4.45)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15383199P | 1999-09-14 | 1999-09-14 | |
| PCT/US2000/021970 WO2001019955A2 (en) | 1999-09-14 | 2000-09-14 | Lysosomal targeting pathway enzymes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02002901A true MXPA02002901A (es) | 2003-10-14 |
Family
ID=22548927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02002901A MXPA02002901A (es) | 1999-09-14 | 2000-09-14 | Enzimas de ruta de enfocado lisosomal. |
Country Status (10)
| Country | Link |
|---|---|
| US (8) | US6534300B1 (es) |
| EP (1) | EP1224266B1 (es) |
| JP (1) | JP2003509043A (es) |
| AT (1) | ATE373086T1 (es) |
| AU (1) | AU783224B2 (es) |
| BR (1) | BR0014514A (es) |
| CA (1) | CA2383217C (es) |
| DE (1) | DE60036395T2 (es) |
| MX (1) | MXPA02002901A (es) |
| WO (1) | WO2001019955A2 (es) |
Families Citing this family (152)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US6534300B1 (en) * | 1999-09-14 | 2003-03-18 | Genzyme Glycobiology Research Institute, Inc. | Methods for producing highly phosphorylated lysosomal hydrolases |
| CA2398995C (en) * | 2000-02-04 | 2014-09-23 | Children's Hospital Research Foundation | Lipid hydrolysis therapy for atherosclerosis and related diseases |
| EP1782825B1 (en) * | 2000-07-18 | 2014-09-10 | Duke University | Treatment of glycogen storage diseases type II |
| ES2523024T3 (es) | 2000-07-18 | 2014-11-20 | Duke University | Tratamiento de glucogenosis de tipo II |
| AU2012200674B2 (en) * | 2000-08-18 | 2014-04-24 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
| US7138262B1 (en) * | 2000-08-18 | 2006-11-21 | Shire Human Genetic Therapies, Inc. | High mannose proteins and methods of making high mannose proteins |
| US7723296B2 (en) * | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| US7001994B2 (en) * | 2001-01-18 | 2006-02-21 | Genzyme Corporation | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins |
| EP1368039A4 (en) * | 2001-02-20 | 2006-03-29 | Uab Research Foundation | AMINOGLYCOSIDE TREATMENT FOR LYSOSOMAL STORAGE DISEASES |
| US7560424B2 (en) * | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| US20040005309A1 (en) * | 2002-05-29 | 2004-01-08 | Symbiontics, Inc. | Targeted therapeutic proteins |
| US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| IL158623A0 (en) * | 2001-04-30 | 2004-05-12 | Symbiontics Inc | Subcellular targeting of therapeutic proteins |
| FR2825268B1 (fr) * | 2001-05-31 | 2004-09-17 | Oreal | Composition cosmetique comprenant des particules de carbonate de calcium et des agents de conditionnement |
| AU2002317700A1 (en) * | 2001-06-07 | 2002-12-16 | Hemebiotech A/S | Production of recombinant human arylsulfatase a |
| JP4742191B2 (ja) * | 2001-06-14 | 2011-08-10 | 独立行政法人産業技術総合研究所 | 糖蛋白質およびその製造方法 |
| US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US8008252B2 (en) * | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
| US7399613B2 (en) * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars |
| US7696163B2 (en) | 2001-10-10 | 2010-04-13 | Novo Nordisk A/S | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7157277B2 (en) | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
| US7179617B2 (en) * | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
| US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| US7795210B2 (en) | 2001-10-10 | 2010-09-14 | Novo Nordisk A/S | Protein remodeling methods and proteins/peptides produced by the methods |
| US20030072761A1 (en) * | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
| ES2291507T3 (es) * | 2001-10-19 | 2008-03-01 | MERCK & CO., INC. | Moduladores de receptor de androgenos y procedimientos de uso de los mismos. |
| WO2003045980A2 (en) * | 2001-11-28 | 2003-06-05 | Neose Technologies, Inc. | Glycopeptide remodeling using amidases |
| US6905856B2 (en) * | 2001-12-21 | 2005-06-14 | Genzyme Glycobiology Research Institute, Inc. | Soluble GlcNAc phosphotransferase |
| US6800472B2 (en) * | 2001-12-21 | 2004-10-05 | Genzyme Glycobiology Research Institute, Inc. | Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase |
| US20030133924A1 (en) * | 2001-12-21 | 2003-07-17 | Novazyme Pharmaceuticals, Inc. | Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease |
| US20050158296A1 (en) | 2002-01-11 | 2005-07-21 | Starr Christopher M. | Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| EP1336411A1 (en) * | 2002-02-14 | 2003-08-20 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases |
| DE60336555D1 (de) | 2002-06-21 | 2011-05-12 | Novo Nordisk Healthcare Ag | Pegylierte glykoformen von faktor vii |
| WO2006002283A1 (en) * | 2004-06-21 | 2006-01-05 | Medtronic, Inc. | Medical systems and methods for delivering compositions to cells |
| NZ542094A (en) | 2003-03-14 | 2008-12-24 | Neose Technologies Inc | Branched polymer conjugates comprising a peptide and water-soluble polymer chains |
| US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
| US20070026485A1 (en) | 2003-04-09 | 2007-02-01 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| EP1613261A4 (en) * | 2003-04-09 | 2011-01-26 | Novo Nordisk As | INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES |
| BRPI0410164A (pt) | 2003-05-09 | 2006-05-16 | Neose Technologies Inc | composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano |
| WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
| US7442372B2 (en) * | 2003-08-29 | 2008-10-28 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
| US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| US7956032B2 (en) * | 2003-12-03 | 2011-06-07 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US20080318850A1 (en) * | 2003-12-03 | 2008-12-25 | Neose Technologies, Inc. | Glycopegylated Factor Ix |
| US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| WO2005070138A2 (en) | 2004-01-08 | 2005-08-04 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
| AU2005211775B2 (en) * | 2004-02-06 | 2009-10-08 | Biomarin Pharmaceutical Inc. | Manufacture of highly phosphorylated lysosomal enzymes and uses thereof |
| EP1716232B9 (en) * | 2004-02-10 | 2010-10-13 | ZyStor Therapeutics , Inc. | Acid alpha-glucosidase and fragments thereof |
| US20050208090A1 (en) * | 2004-03-18 | 2005-09-22 | Medtronic, Inc. | Methods and systems for treatment of neurological diseases of the central nervous system |
| WO2006007560A2 (en) | 2004-07-01 | 2006-01-19 | University Of Pennsylvania | Targeted protein replacement for the treatment of lysosomal storage disorders |
| WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| US8268967B2 (en) | 2004-09-10 | 2012-09-18 | Novo Nordisk A/S | Glycopegylated interferon α |
| ES2566670T3 (es) | 2004-10-29 | 2016-04-14 | Ratiopharm Gmbh | Remodelación y glucopegilación del factor de crecimiento de fibroblastos (FGF) |
| JP4951527B2 (ja) | 2005-01-10 | 2012-06-13 | バイオジェネリックス アーゲー | 糖ｐｅｇ化顆粒球コロニー刺激因子 |
| JP2008533175A (ja) * | 2005-03-16 | 2008-08-21 | ユニバーシティ・オブ・オックスフォード | Ｈｉｖ−１のためのマンノース免疫原 |
| US20060246544A1 (en) * | 2005-03-30 | 2006-11-02 | Neose Technologies,Inc. | Manufacturing process for the production of peptides grown in insect cell lines |
| US20070154992A1 (en) * | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| MX2007014470A (es) | 2005-05-17 | 2008-02-06 | Amicus Therapeutics Inc | Metodo para el tratamiento de enfermedad de pompe usando derivados de 1-desoxinojirimicina. |
| EP2975135A1 (en) * | 2005-05-25 | 2016-01-20 | Novo Nordisk A/S | Glycopegylated factor IX |
| WO2006127910A2 (en) | 2005-05-25 | 2006-11-30 | Neose Technologies, Inc. | Glycopegylated erythropoietin formulations |
| US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| US20090297496A1 (en) * | 2005-09-08 | 2009-12-03 | Childrens Hospital Medical Center | Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases |
| PL1945665T3 (pl) * | 2005-10-21 | 2012-02-29 | Genzyme Corp | Leki oparte na przeciwciałach z ulepszoną aktywnością adcc |
| US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
| ES2391657T3 (es) | 2006-02-07 | 2012-11-28 | Shire Human Genetic Therapies, Inc. | Composiciones estabilizadas de proteínas que tienen un resto tiol libre |
| US20080248959A1 (en) * | 2006-07-21 | 2008-10-09 | Neose Technologies, Inc. | Glycosylation of peptides via o-linked glycosylation sequences |
| EP2054521A4 (en) | 2006-10-03 | 2012-12-19 | Novo Nordisk As | PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES |
| US20080207487A1 (en) * | 2006-11-02 | 2008-08-28 | Neose Technologies, Inc. | Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| AU2007322123A1 (en) * | 2006-11-13 | 2008-05-29 | Biomarin Pharmaceutical Inc. | Methods for treating Pompe disease |
| EP2457919B1 (en) * | 2007-01-18 | 2019-06-05 | Genzyme Corporation | Oligosaccharides comprising an aminooxy group and conjugates thereof |
| KR20090103939A (ko) * | 2007-01-29 | 2009-10-01 | 유나이티드 세러퓨틱스 코오포레이션 | 당 면역원 |
| WO2008112525A2 (en) * | 2007-03-09 | 2008-09-18 | Link Medicine Corporation | Treatment of lysosomal storage diseases |
| PL2144923T3 (pl) | 2007-04-03 | 2013-12-31 | Biogenerix Ag | Sposoby leczenia z użyciem glikopegilowanego G-CSF |
| US20090053167A1 (en) * | 2007-05-14 | 2009-02-26 | Neose Technologies, Inc. | C-, S- and N-glycosylation of peptides |
| EP2170919B8 (en) | 2007-06-12 | 2016-01-20 | ratiopharm GmbH | Improved process for the production of nucleotide sugars |
| US8207112B2 (en) | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
| PL3219795T3 (pl) | 2008-01-18 | 2024-09-16 | Biomarin Pharmaceutical Inc. | Wytwarzanie aktywnych wysoce fosforylowanych ludzkich enzymów sulfatazy lizosomalnej i ich zastosowania |
| US7722865B2 (en) | 2008-01-18 | 2010-05-25 | Biomarin Pharmaceutical Inc. | Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
| EP2626079A3 (en) | 2008-02-27 | 2014-03-05 | Novo Nordisk A/S | Conjungated factor VIII molecules |
| CA2723412A1 (en) * | 2008-05-07 | 2009-11-12 | Zystor Therapeutics, Inc. | Lysosomal targeting peptides and uses thereof |
| HUE060974T2 (hu) | 2008-12-16 | 2023-04-28 | Genzyme Corp | Szintetikus intermedierek oligoszacharid-fehérje konjugátumok elõállítására |
| EP2475376B1 (en) | 2009-06-17 | 2016-03-30 | BioMarin Pharmaceutical Inc. | Formulations for lysosomal enzymes |
| MX379016B (es) | 2009-07-28 | 2025-03-10 | Takeda Pharmaceuticals Co | Composiciones y metodos para tratar enfermedad de gaucher. |
| US20110039300A1 (en) * | 2009-08-10 | 2011-02-17 | Robert Bayer | Antibodies with enhanced adcc functions |
| SI3482767T1 (sl) | 2009-08-28 | 2022-03-31 | Icahn School Of Medicine At Mount Sinai | Encimska nadomestna terapija s povečevanjem odmerkov za zdravljenje pomanjkanja kisle sfingomielinaze |
| WO2011028941A2 (en) | 2009-09-04 | 2011-03-10 | The United States Of America, As Represented By The Secretary Department Of Health & Human Services | Disabling autophagy as a treatment for lysosomal storage diseases |
| WO2011034951A2 (en) * | 2009-09-15 | 2011-03-24 | The Regents Of The University Of California | Assisted enzyme replacement therapy |
| HUE062163T2 (hu) | 2010-04-23 | 2023-09-28 | Alexion Pharma Inc | Lizoszomális tárolási betegséggel asszociált enzim |
| PE20130589A1 (es) | 2010-06-25 | 2013-05-19 | Shire Human Genetic Therapies | Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a |
| RS59469B1 (sr) | 2010-06-25 | 2019-11-29 | Shire Human Genetic Therapies | Postupci i kompozicije za isporuku iduronat-2-sulfataze u cns |
| HRP20191923T1 (hr) | 2010-06-25 | 2020-01-10 | Shire Human Genetic Therapies, Inc. | Postupci i sastavi za isporuku arilsulfataze a u cns |
| SMT201600385T1 (it) | 2010-06-25 | 2017-03-08 | Shire Human Genetic Therapies | Trasporto di agenti terapeutici all’snc |
| US9320711B2 (en) | 2010-06-25 | 2016-04-26 | Shire Human Genetic Therapies, Inc. | Methods and compositions for CNS delivery of heparan N-sulfatase |
| AU2011270672B2 (en) | 2010-06-25 | 2017-01-12 | Shire Human Genetic Therapies, Inc. | Treatment of Sanfilippo Syndrome type B |
| US9453847B2 (en) | 2010-07-19 | 2016-09-27 | Shire Human Genetic Therapies, Inc. | Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof |
| AR082319A1 (es) | 2010-07-22 | 2012-11-28 | Biomarin Pharm Inc | Produccion de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos |
| EP3650039A1 (en) | 2010-09-09 | 2020-05-13 | Alexion Pharmaceuticals, Inc. | Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| WO2012101671A1 (en) * | 2011-01-25 | 2012-08-02 | Jcr Pharmaceuticals Co., Ltd. | Method for production of human recombinant iduronate 2-sulfatase |
| EP2675472A4 (en) | 2011-02-15 | 2014-09-17 | Synageva Biopharma Corp | METHOD FOR THE TREATMENT OF LACK OF LYSOSOMAL SAURER LIPASE |
| JP5665065B2 (ja) | 2011-04-28 | 2015-02-04 | 国立大学法人大阪大学 | リソソーム病治療用医薬組成物 |
| BR112014002219A2 (pt) | 2011-07-05 | 2018-08-07 | Bioasis Technologies Inc | conjugados anticorpo p97 e métodos de sua utilização |
| EP3741384A1 (en) | 2011-09-07 | 2020-11-25 | Mount Sinai School Of Medicine | Ceramidase and cell differentiation |
| CA2852027A1 (en) * | 2011-10-12 | 2013-04-18 | Synageva Biopharma Corp. | Recombinant human naglu protein and uses thereof |
| EP2793922B1 (en) | 2011-12-23 | 2019-10-30 | Shire Human Genetic Therapies, Inc. | Stable formulations for cns delivery of arylsulfatase a |
| EP2793933B1 (en) | 2011-12-23 | 2019-04-17 | Shire Human Genetic Therapies, Inc. | Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase |
| JP6230160B2 (ja) | 2012-03-02 | 2017-11-15 | シャイア ヒューマン ジェネティック セラピーズ インコーポレイテッド | Ｉｉｉ型ゴーシェ病を治療するための組成物および方法 |
| WO2013134530A1 (en) | 2012-03-07 | 2013-09-12 | Amicus Therapeutics, Inc. | High concentration alpha-glucosidase compositions for the treatment of pompe disease |
| AU2013240306A1 (en) | 2012-03-30 | 2014-10-09 | Shire Human Genetic Therapies, Inc. | Subcutaneous administration of iduronate- 2-sulfatase |
| US20150086530A1 (en) | 2012-05-03 | 2015-03-26 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of pompe disease |
| CA2874146C (en) | 2012-06-01 | 2023-03-21 | Icahn School Of Medicine At Mount Sinai | Ceramide levels in the treatment and prevention of infections |
| CN104662150B (zh) * | 2012-07-31 | 2018-07-10 | 比奥阿赛斯技术有限公司 | 脱磷酸化的溶酶体贮积症蛋白及其使用方法 |
| US20150313971A1 (en) | 2012-12-07 | 2015-11-05 | Shire Human Genetic Therapies | Methods and compositions for intrathecally administered treatment of mucupolysaccharidosis type iiia |
| JP2016514096A (ja) | 2013-02-20 | 2016-05-19 | バレリオン セラピューティクス， エルエルシー | ポンぺ病の処置のための方法および組成物 |
| ES2774549T3 (es) | 2013-03-13 | 2020-07-21 | Bioasis Technologies Inc | Fragmentos de P97 y usos de los mismos |
| JP6832158B2 (ja) | 2013-03-14 | 2021-02-24 | アイカーン スクール オブ メディシン アット マウント サイナイ | 治療用酸性セラミダーゼ組成物ならびにそれを作製および使用する方法 |
| US10751283B2 (en) | 2014-01-14 | 2020-08-25 | Capability Building, Inc. | Liposomal rehydration salt formulation and associated methods of use |
| AR094658A1 (es) * | 2014-01-14 | 2015-08-19 | Fast Rehydration Llc | Formulación de sales de rehidratación liposomal |
| US20160347821A1 (en) | 2014-02-03 | 2016-12-01 | Bioasis Technologies, Inc. | P97 fusion proteins |
| AU2015219339B2 (en) | 2014-02-19 | 2020-03-05 | Bioasis Technologies Inc. | P97-IDS fusion proteins |
| CA2943890A1 (en) | 2014-05-01 | 2015-11-05 | Bioasis Technologies, Inc. | P97-polynucleotide conjugates |
| US10413597B2 (en) | 2014-09-29 | 2019-09-17 | Alexion Pharmaceuticals, Inc. | Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB) |
| KR102741048B1 (ko) | 2014-09-30 | 2024-12-11 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 개선된 탄수화물을 가지는 고도로 강력한 산성 알파-글루코시다제 |
| US10639356B2 (en) | 2015-07-20 | 2020-05-05 | Shire Human Genetic Therapies, Inc. | Treatment of cognitive impairment of mucopolysaccharidosis type IIIA by intrathecal delivery of heparan N-sulfatase |
| EP3909983A1 (en) | 2015-12-02 | 2021-11-17 | STCube & Co. Inc. | Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof |
| EP3390644B1 (en) * | 2015-12-15 | 2024-07-31 | Genzyme Corporation | Adeno-associated viral vectors for treating mucolipidosis type ii |
| CA3010205A1 (en) | 2015-12-30 | 2017-07-06 | Amicus Therapeutics, Inc. | Augmented acid alpha-glucosidase for the treatment of pompe disease |
| DK3397270T5 (da) * | 2015-12-30 | 2024-09-23 | Green Cross Corp | Sammensætninger til anvendelse i behandlingen af hunters syndrom |
| MA44237A (fr) | 2016-02-17 | 2021-06-02 | Takeda Pharmaceuticals Co | Méthodes et compositions pour l'administration au système nerveux cental d'arylsulfatase a |
| RU2751235C2 (ru) | 2016-02-24 | 2021-07-12 | Байомарин Фармасьютикал Инк. | Терапевтические слитые белки направленного действия на основе лизосомных ферментов, соответствующие составы и их применения |
| MX2018011951A (es) | 2016-03-30 | 2019-02-13 | Amicus Therapeutics Inc | Metodo para seleccionar proteinas recombinantes ricas en m6p. |
| KR20250017756A (ko) | 2016-03-30 | 2025-02-04 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 재조합 산 알파-글루코시다제를 포함하는 제형 |
| NL2017294B1 (en) | 2016-08-05 | 2018-02-14 | Univ Erasmus Med Ct Rotterdam | Natural cryptic exon removal by pairs of antisense oligonucleotides. |
| US10449230B2 (en) | 2016-10-06 | 2019-10-22 | The Regents Of The University Of California | Polymyxin derived cell penetrating scaffolds |
| CN110621774A (zh) | 2016-10-14 | 2019-12-27 | 儿童医疗中心有限公司 | 用于治疗中枢神经系统疾病和病症的组合物和方法 |
| TW201829770A (zh) * | 2017-01-10 | 2018-08-16 | 美商阿米庫斯醫療股份有限公司 | 用於治療fabry氏病之重組α-半乳糖苷酶A |
| EP3570670B1 (en) * | 2017-01-17 | 2024-03-06 | Children's Medical Center Corporation | Compositions and methods for treating lysosomal storage diseases and disorders |
| EP3571310A4 (en) | 2017-01-17 | 2020-12-16 | Children's Medical Center Corporation | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PEROXYSOMAL DISEASES |
| EP3357489A1 (en) | 2017-02-03 | 2018-08-08 | Rheinische Friedrich-Wilhelms-Universität Bonn | Mutated arylsulfatase a |
| HRP20230576T1 (hr) | 2017-05-15 | 2023-09-01 | Amicus Therapeutics, Inc. | Rekombinantna ljudska kisela alfa-glukozidaza |
| KR102861670B1 (ko) | 2017-05-31 | 2025-09-18 | 주식회사 에스티큐브앤컴퍼니 | Btn1a1에 면역특이적으로 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법 |
| EP3630835A1 (en) | 2017-05-31 | 2020-04-08 | STCube & Co., Inc. | Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof |
| JP2020522562A (ja) | 2017-06-06 | 2020-07-30 | ストキューブ アンド シーオー．， インコーポレイテッド | Ｂｔｎ１ａ１又はｂｔｎ１ａ１リガンドに結合する抗体及び分子を用いて癌を治療する方法 |
| KR101942093B1 (ko) * | 2018-01-05 | 2019-01-24 | 인하대학교 산학협력단 | 만노시다제 억제제를 포함하는 고만노즈 타입 n-당쇄를 갖는 인간 리소좀 효소 생산용 조성물 |
| WO2020046132A1 (en) | 2018-08-31 | 2020-03-05 | Leiden University | Pharmacological chaperones for enzyme treatment therapy |
| EP4043562A1 (en) | 2021-02-16 | 2022-08-17 | Rheinische Friedrich-Wilhelms-Universität Bonn | Mutated arylsulfatase a with increased stability |
| JP2025512955A (ja) * | 2022-04-05 | 2025-04-22 | アステラス ジーン セラピーズ，インコーポレーテッド | アデノ随伴ウイルス力価アッセイおよびその使用 |
| AU2023265155A1 (en) | 2022-05-05 | 2024-12-12 | Amicus Therapeutics, Inc. | Methods for treating pompe disease |
| WO2023220649A2 (en) * | 2022-05-10 | 2023-11-16 | Mammoth Biosciences, Inc. | Effector protein compositions and methods of use thereof |
| EP4626465A1 (en) | 2022-12-02 | 2025-10-08 | Amicus Therapeutics, Inc. | Methods for treating late onset pompe disease in pediatric patients |
| AU2023406510A1 (en) | 2022-12-02 | 2025-07-10 | Amicus Therapeutics, Inc. | Fexamethods for treating infantile-onset pompe disease in pediatric patients |
Family Cites Families (127)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US583711A (en) * | 1897-06-01 | Detergent and process of producing same | ||
| US4140107A (en) | 1972-12-28 | 1979-02-20 | Erasmus University Rotterdam | Echoscope for examination of objects |
| CH585793A5 (es) | 1974-02-01 | 1977-03-15 | Nestle Sa | |
| JPS5322158B2 (es) | 1974-05-02 | 1978-07-06 | ||
| US3957578A (en) | 1975-01-03 | 1976-05-18 | Hokkaido Sugar Co., Ltd. | Method for manufacture of α-galactosidase by microorganism |
| US4328215A (en) | 1977-05-09 | 1982-05-04 | The Johns Hopkins University | Method of reducing or avoiding the mutagenic activity of drugs |
| NL7706429A (nl) | 1977-06-10 | 1978-12-12 | Univ Erasmus | Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking. |
| US4195126A (en) | 1977-10-04 | 1980-03-25 | The Board Of Trustees Of The University Of Alabama | Albumin-dye complex for fatty acid determination |
| USRE35770E (en) | 1978-11-06 | 1998-04-14 | Choay, S.A. | Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them |
| IL61201A (en) | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
| US4332894A (en) | 1980-08-15 | 1982-06-01 | Purdue Research Foundation | Conversion of guar gum to gel-forming polysaccharides by the action of α-galactosidase |
| US4496722A (en) | 1981-05-01 | 1985-01-29 | The Children's Medical Center Corporation | Reporter compounds |
| US4659817A (en) | 1981-05-01 | 1987-04-21 | The Children's Medical Center Corporation | Reporter compounds containing boron |
| DE3122216A1 (de) | 1981-06-04 | 1982-12-23 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung eines mikroorganismus, welcher (alpha)-galactosidase, aber keine invertase bildet, so erhaltener mikroorganismus und seine verwendung |
| US4433946A (en) | 1981-07-21 | 1984-02-28 | Christianson Systems, Inc. | Discharge system for grain handling apparatus |
| IT1140312B (it) | 1981-12-03 | 1986-09-24 | Anic Spa | Procedimento per la produzione di alfa-galattosidasi e impieghi dell'enzima cosi' ottenuto |
| NL8105635A (nl) | 1981-12-15 | 1983-07-01 | Univ Erasmus | Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking. |
| US4987223A (en) | 1981-12-23 | 1991-01-22 | Choay S.A. | Derivatives of the uronic acid |
| US4749570A (en) | 1981-12-31 | 1988-06-07 | The Governors Of The University Of Alberta | Targeting conjugates of albumin and therapeutic agents |
| US4492761A (en) | 1982-04-05 | 1985-01-08 | Duke University | Complement assay method |
| NL189547C (nl) | 1983-04-12 | 1993-05-17 | Univ Erasmus | Stelsel voor het bepalen van de stroomsterkte van het hart van een patient. |
| SE440973B (sv) | 1984-02-02 | 1985-09-02 | Trelleborg Ab | Anleggning for fiskodling i oppen sjo med flytkroppar ledbart forbundna med varandra och stabiliserade med en tyngdbelastad kjol anleggning for fiskodling i oppen sjo med flytkroppar ledbart forbundna med varandra och stabiliserade med en tyngdbelastad kjol |
| JPS60241884A (ja) | 1984-05-15 | 1985-11-30 | Tokyo Daigaku | 自動サイクリング反応装置およびこれを用いる自動分析装置 |
| US5001072A (en) | 1984-05-23 | 1991-03-19 | Icn Biomedicals Inc. | Compositions and methods for multiple simultaneous immunoradiometric assay (IRMA) of analytes using radioisotope chelate labels |
| US5691181A (en) | 1984-08-21 | 1997-11-25 | Celltech Limited | DNA encoding lipase from human gastric mucosal tissue |
| US4986274A (en) | 1984-10-19 | 1991-01-22 | Stephens John D | Fetal anatomic sex assignment by ultrasonography during early pregnancy |
| US4639420A (en) | 1984-11-21 | 1987-01-27 | Schaffner Carl P | Method for the immunoanalysis of cholesterol epoxides |
| US4615884A (en) | 1985-04-09 | 1986-10-07 | Vanderbilt University | Method and vaccine for treatment of demyelinating diseases |
| JPH0669953B2 (ja) | 1985-08-16 | 1994-09-07 | 日産化学工業株式会社 | 脳脊髄系神経栄養剤 |
| CA1339101C (en) | 1986-06-03 | 1997-07-29 | Nicolaas Overbeeke | Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods |
| US5217865A (en) | 1986-07-25 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Screening for Tay-Sachs disease with cloned DNA for beta-hexosaminidase |
| FR2603804B1 (fr) | 1986-09-17 | 1989-10-27 | Jouveinal Sa | Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique |
| GB8630721D0 (en) | 1986-12-23 | 1987-02-04 | Unilever Plc | Cosmetic compositions |
| EP0279582A3 (en) | 1987-02-17 | 1989-10-18 | Pharming B.V. | Dna sequences to target proteins to the mammary gland for efficient secretion |
| US5055401A (en) | 1987-04-10 | 1991-10-08 | Alko Ltd. | Construction of new α-galactosidase producing yeast strains and the industrial application of these strains |
| US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
| US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
| JPS6460379A (en) | 1987-08-28 | 1989-03-07 | Toyo Jozo Kk | Novel ganglioside ceramidase and production thereof |
| US5143841A (en) | 1987-08-28 | 1992-09-01 | Toyo Jozo Company, Ltd. | Ganglioside ceramidase and process for producing same |
| DE3732871A1 (de) | 1987-09-30 | 1989-04-20 | Behringwerke Ag | Chromogene substrate |
| US4866042A (en) | 1987-11-18 | 1989-09-12 | Neuwelt Edward A | Method for the delivery of genetic material across the blood brain barrier |
| US4868042A (en) | 1987-12-09 | 1989-09-19 | Pall Corporation | Antiwicking compositions and fabrics treated therewith |
| US5639939A (en) | 1987-12-23 | 1997-06-17 | The Board Of Trustees For The Leland Stanford Junior University | Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue |
| US5126247A (en) | 1988-02-26 | 1992-06-30 | Enzymatics, Inc. | Method, system and devices for the assay and detection of biochemical molecules |
| GB8806892D0 (en) | 1988-03-23 | 1988-04-27 | Unilever Plc | Lactams their synthesis & use in cosmetic compositions |
| US5310646A (en) | 1988-05-13 | 1994-05-10 | Regents Of The University Of Minnesota | Method for the detection of mucopolysaccharide storage diseases |
| US5202253A (en) | 1988-12-30 | 1993-04-13 | Oklahoma Medical Research Foundation | Monoclonal antibody specific for protein C and antibody purification method |
| US5583160A (en) | 1989-02-03 | 1996-12-10 | The Biomembrane Institute | Methylsphingosine used to treat apoptosis |
| US5929036A (en) | 1989-03-08 | 1999-07-27 | The Board Of Regents Of The University Of Oklahoma | Ligand or GMP-140 selectin and methods of use thereof |
| US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
| US5179023A (en) | 1989-03-24 | 1993-01-12 | Research Corporation Technologies, Inc. | Recombinant α-galactosidase a therapy for Fabry disease |
| DE3916729A1 (de) | 1989-05-23 | 1990-12-06 | Behringwerke Ag | Fluorogene verbindungen und ihre verwendung |
| US5281394A (en) | 1989-07-21 | 1994-01-25 | Icn Biomedicals, Inc. | Data collection and sample handling apparatus |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5060428A (en) | 1990-02-09 | 1991-10-29 | Resco Products, Inc. | Prefabricated walls |
| US5089392A (en) | 1990-03-30 | 1992-02-18 | The United States Of America As Represented By Of The Department Of Health And Human Services | Fluorogenic substrates for measurement of lysosomal enzyme activities within intact cells |
| US5061025A (en) | 1990-04-13 | 1991-10-29 | Eastman Kodak Company | Hologon scanner with beam shaping stationary diffraction grating |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| US5316908A (en) | 1990-07-13 | 1994-05-31 | Life Technologies, Inc. | Size markers for electrophoretic analysis of DNA |
| CA2090473A1 (en) | 1990-08-29 | 1992-03-01 | Robert M. Kay | Homologous recombinatin in mammalian cells |
| US5382524A (en) | 1990-10-24 | 1995-01-17 | The Mount Sinai School Of Medicine Of The City University Of New York | Cloning and expression of biologically active α-n-acetylgalactosaminidase |
| US5356804A (en) | 1990-10-24 | 1994-10-18 | Mount Sinai School Of Medicine Of The City Of New York | Cloning and expression of biologically active human α-galactosidase A |
| US5401650A (en) | 1990-10-24 | 1995-03-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Cloning and expression of biologically active α-galactosidase A |
| US5208148A (en) | 1990-12-07 | 1993-05-04 | Molecular Probes, Inc. | Lipophilic fluorescent glycosidase substrates |
| CZ281418B6 (cs) | 1991-02-15 | 1996-09-11 | Sankyo Company Limited | 2-amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyklopent/d/oxazol-4,5,6-triol,způsob výroby a produkční mikroorganismy |
| US5773278A (en) | 1991-05-03 | 1998-06-30 | Mount Sinai Medical Center | Acid sphingomyelinase gene |
| US5205917A (en) | 1991-05-07 | 1993-04-27 | Glyko, Inc. | Fluorophore assisted carbohydrate electrophoresis diagnosis |
| JPH06509711A (ja) | 1991-08-07 | 1994-11-02 | マウント シナイ スクール オブ メディスン オブ ザ シティー ユニバーシティー オブ ニューヨーク | 鉛中毒に対する感受性を測定する方法 |
| US5242805A (en) | 1991-08-23 | 1993-09-07 | Molecular Probes, Inc. | Long wavelength lipophilic fluorogenic glycosidase substrates |
| US5576424A (en) | 1991-08-23 | 1996-11-19 | Molecular Probes, Inc. | Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells |
| US5316906A (en) | 1991-08-23 | 1994-05-31 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
| ATE180018T1 (de) | 1991-08-23 | 1999-05-15 | Molecular Probes Inc | Verwendung von haloalkylderivaten von reportermolekülen zur analyse der metabolischen aktivität in zellen |
| NL9101680A (nl) | 1991-10-04 | 1993-05-03 | Tno | Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren. |
| US5433946A (en) | 1991-10-11 | 1995-07-18 | Health Research Inc. | Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases |
| US5733761A (en) | 1991-11-05 | 1998-03-31 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| CA2123098A1 (en) | 1991-11-06 | 1993-05-13 | David Dime | Immunostimulating swainsonine analogs |
| US5932211A (en) | 1991-11-12 | 1999-08-03 | Women's And Children's Hospital | Glycosylation variants of iduronate 2-sulfatase |
| GB9207288D0 (en) | 1992-04-02 | 1992-05-13 | Unilever Plc | Cosmetic composition |
| GB9207280D0 (en) | 1992-04-02 | 1992-05-13 | Unilever Plc | Skin care method and composition |
| DE69312142T2 (de) | 1992-04-02 | 1998-02-05 | Philips Electronics Nv | Verfahren zum Herstellen einer zugespitzten Elektrode |
| US5578479A (en) | 1992-06-09 | 1996-11-26 | The Johns Hopkins University | Alpha-amylase from hyperthermophilic archaebacterium |
| US5366883A (en) | 1992-06-09 | 1994-11-22 | Takara Shuzo Co., Ltd. | α-amylase gene |
| WO1993025219A1 (en) | 1992-06-12 | 1993-12-23 | Cephalon, Inc. | Prevention and treatment of peripheral neuropathy |
| US5420112A (en) | 1992-06-12 | 1995-05-30 | Lewis; Michael E. | Prevention and treatment of peripheral neuropathy |
| WO1994004672A1 (en) | 1992-08-26 | 1994-03-03 | Dnx Corp. | Tetracycline repressor-mediated binary regulation system for control of gene expression in transgenic animals |
| US5449604A (en) | 1992-10-21 | 1995-09-12 | University Of Washington | Chromosome 14 and familial Alzheimers disease genetic markers and assays |
| CA2147887A1 (en) | 1992-10-30 | 1994-05-11 | James W. Dennis | Method for measuring glycosyltransferase activity |
| US5512471A (en) | 1992-12-23 | 1996-04-30 | The Curators Of The University Of Missouri | Process for purifying an α-D-galactosidase isozyme from Coffea beans |
| US5667839A (en) | 1993-01-28 | 1997-09-16 | Collagen Corporation | Human recombinant collagen in the milk of transgenic animals |
| DK38893D0 (da) | 1993-03-31 | 1993-03-31 | Novo Nordisk As | Dna |
| ATE223493T1 (de) | 1993-04-21 | 2002-09-15 | Pasteur Institut | Biokompatibles implantat zur in vivo expression und sekretion von therapeutischer verbindung |
| US5798366A (en) | 1993-05-13 | 1998-08-25 | Monsanto Company | Method for treatment of CNS-involved lysosomal storage diseases |
| US5736360A (en) | 1993-09-10 | 1998-04-07 | The Trustees Of The University Of Pennsylvania | Endothelial cell tropic compositions and methods of making and using the same |
| AU7656894A (en) | 1993-09-15 | 1995-04-03 | Unilever Plc | Skin care method and composition |
| GB9319104D0 (en) | 1993-09-15 | 1993-11-03 | Unilever Plc | Skin care method & composition |
| US5491076A (en) | 1993-11-01 | 1996-02-13 | The Texas A&M University System | Expression of foreign genes using a replicating polyprotein producing virus vector |
| US5405751A (en) | 1994-01-12 | 1995-04-11 | Schering Corporation | Prenatal diagnosis by cytokine-induced proliferation of fetal T-cells |
| JPH09509165A (ja) | 1994-02-16 | 1997-09-16 | ファーミング ベスローテン フェンノートシャップ | ミルクからのラクトフェリンの分離 |
| US5627171A (en) | 1994-04-11 | 1997-05-06 | Oncomembrane, Inc. | Sphingosine-1-phosphate/trimethylsphingosine composition |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| ATE339503T1 (de) | 1994-04-25 | 2006-10-15 | Genentech Inc | Cardiotrophin und verwendung davon |
| US5716614A (en) | 1994-08-05 | 1998-02-10 | Molecular/Structural Biotechnologies, Inc. | Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier |
| AU3258295A (en) | 1994-09-08 | 1996-03-27 | Boehringer Mannheim Gmbh | Retroviral vector hybrids and the use thereof for gene transfer |
| US5798448A (en) | 1994-10-27 | 1998-08-25 | Genentech, Inc. | AL-1 neurotrophic factor antibodies |
| US5707865A (en) | 1994-12-21 | 1998-01-13 | Kohn; Donald B. | Retroviral vectors for expression in embryonic cells |
| US5792647A (en) | 1995-02-13 | 1998-08-11 | The Johns Hopkins University | Bacterial catabolism of chitin |
| JPH08271784A (ja) | 1995-03-30 | 1996-10-18 | Canon Inc | 視線検出機能付き光学機器 |
| US5871946A (en) | 1995-05-18 | 1999-02-16 | Coulter Corporation | Method for determining activity of enzymes in metabolically active whole cells |
| US5663254A (en) | 1995-05-22 | 1997-09-02 | The Johns Hopkins University | Synthesis of high mannose glycopolymers |
| US5704910A (en) | 1995-06-05 | 1998-01-06 | Nephros Therapeutics, Inc. | Implantable device and use therefor |
| US5928928A (en) | 1995-06-07 | 1999-07-27 | Universiteit Van Amsterdam | Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| US6118045A (en) | 1995-08-02 | 2000-09-12 | Pharming B.V. | Lysosomal proteins produced in the milk of transgenic animals |
| US5663076A (en) | 1995-08-08 | 1997-09-02 | Lsi Logic Corporation | Automating photolithography in the fabrication of integrated circuits |
| US5914231A (en) | 1995-08-17 | 1999-06-22 | Universiteit Utrecht Introgene B.V. | Poly(organo)phosphazenes for use in synthetic transfection systems |
| DE69637875D1 (de) | 1995-09-14 | 2009-04-30 | Virginia Tech Intell Prop | Produktion von lysosomalen enzymen in pflanzlichen expressionssystemen |
| WO1997010817A1 (en) | 1995-09-20 | 1997-03-27 | The Regents Of The University Of Michigan | Amino ceramide-like compounds and therapeutic methods of use |
| US6048964A (en) | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| US5858351A (en) | 1996-01-18 | 1999-01-12 | Avigen, Inc. | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
| US5830916A (en) | 1996-05-23 | 1998-11-03 | Duke University | Inhibitor of ceramidase |
| US5719031A (en) | 1996-08-14 | 1998-02-17 | Molecular Probes, Inc. | Dye labeled polymers as reagents for measuring polymer degradation |
| US5830850A (en) | 1996-08-28 | 1998-11-03 | Mount Sinai School Of Medicine Of The City Of New York | Methods for the treatment of bone resorption disorders, including osteoporosis |
| JPH1080280A (ja) | 1996-09-09 | 1998-03-31 | Shimadzu Corp | 核酸合成法 |
| US5773236A (en) | 1997-04-25 | 1998-06-30 | Molecule Probes, Inc. | Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules |
| US5939279A (en) | 1997-09-18 | 1999-08-17 | The Board Of Trustees Of The University Of Arkansas | Inhibition of bacterial binding by high-mannose oligosaccharides |
| EP1040117A4 (en) * | 1997-12-18 | 2005-03-09 | Human Genome Sciences Inc | 110 HUMAN SECRETATED PROTEINS |
| US6534300B1 (en) | 1999-09-14 | 2003-03-18 | Genzyme Glycobiology Research Institute, Inc. | Methods for producing highly phosphorylated lysosomal hydrolases |
| US6800472B2 (en) * | 2001-12-21 | 2004-10-05 | Genzyme Glycobiology Research Institute, Inc. | Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase |
-
2000
- 2000-08-10 US US09/635,872 patent/US6534300B1/en not_active Expired - Lifetime
- 2000-08-10 US US09/636,077 patent/US6537785B1/en not_active Expired - Lifetime
- 2000-08-10 US US09/636,060 patent/US6642038B1/en not_active Expired - Lifetime
- 2000-09-14 JP JP2001523727A patent/JP2003509043A/ja active Pending
- 2000-09-14 WO PCT/US2000/021970 patent/WO2001019955A2/en not_active Ceased
- 2000-09-14 MX MXPA02002901A patent/MXPA02002901A/es unknown
- 2000-09-14 BR BR0014514-9A patent/BR0014514A/pt not_active IP Right Cessation
- 2000-09-14 AT AT00961335T patent/ATE373086T1/de not_active IP Right Cessation
- 2000-09-14 AU AU73303/00A patent/AU783224B2/en not_active Expired
- 2000-09-14 DE DE60036395T patent/DE60036395T2/de not_active Expired - Lifetime
- 2000-09-14 EP EP00961335A patent/EP1224266B1/en not_active Expired - Lifetime
- 2000-09-14 CA CA2383217A patent/CA2383217C/en not_active Expired - Lifetime
-
2001
- 2001-07-02 US US09/895,072 patent/US6861242B2/en not_active Expired - Lifetime
- 2001-11-09 US US09/986,552 patent/US6670165B2/en not_active Expired - Lifetime
-
2003
- 2003-09-09 US US10/657,280 patent/US7067127B2/en not_active Expired - Lifetime
-
2005
- 2005-08-09 US US11/199,233 patent/US7371366B2/en not_active Expired - Lifetime
-
2008
- 2008-02-27 US US12/038,018 patent/US20080176285A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2383217A1 (en) | 2001-03-22 |
| DE60036395T2 (de) | 2008-06-12 |
| EP1224266B1 (en) | 2007-09-12 |
| US6861242B2 (en) | 2005-03-01 |
| BR0014514A (pt) | 2002-07-23 |
| US20020025550A1 (en) | 2002-02-28 |
| US6642038B1 (en) | 2003-11-04 |
| US20080176285A1 (en) | 2008-07-24 |
| JP2003509043A (ja) | 2003-03-11 |
| US6534300B1 (en) | 2003-03-18 |
| US6537785B1 (en) | 2003-03-25 |
| AU783224B2 (en) | 2005-10-06 |
| EP1224266A4 (en) | 2003-05-28 |
| AU7330300A (en) | 2001-04-17 |
| DE60036395D1 (de) | 2007-10-25 |
| US7067127B2 (en) | 2006-06-27 |
| WO2001019955A3 (en) | 2001-10-04 |
| US6670165B2 (en) | 2003-12-30 |
| US20060073498A1 (en) | 2006-04-06 |
| CA2383217C (en) | 2013-11-19 |
| US20020150981A1 (en) | 2002-10-17 |
| ATE373086T1 (de) | 2007-09-15 |
| US7371366B2 (en) | 2008-05-13 |
| EP1224266A2 (en) | 2002-07-24 |
| US20050089869A1 (en) | 2005-04-28 |
| WO2001019955A2 (en) | 2001-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1224266A4 (en) | ENZYMES WITH LYSOSOMIAL TARGETING | |
| WO1999057325A3 (en) | Enzymes mixture | |
| WO2001097829A3 (en) | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases | |
| DE60021160D1 (de) | Protein-deamiderendes Enzym, dafür kodierendes Gen, enzym-produzierendes Mikroorganismus, Verfahren zur Herstellung und Verwendung davon | |
| WO2001047944A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| AU2002366285A8 (en) | Ides, an igg-degrading enzyme of streptococcus pyogenes | |
| EP2333097A3 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| DK0976829T3 (da) | Protein-deamiderende enzym, gen kodende for dette, fremgangsmåde til fremstilling heraf same anvendelse heraf | |
| WO1997026270A3 (en) | Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules | |
| MXPA03005960A (es) | Nuevas mezclas de enzimas microbianas. | |
| AU5630999A (en) | Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection | |
| WO2002010358A3 (en) | Nucleotide incorporating enzymes | |
| WO2005049842A3 (en) | Improved targeted dna insertion in plants | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| WO2006063055A3 (en) | Enzyme conjugates for use as detoxifying agents | |
| WO2000029623A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| AU2003235506A8 (en) | Targeted enzymes and methods of making and using targeted enzymes. | |
| GB0020331D0 (en) | Enzyme | |
| IL155878A0 (en) | Isolated luciferases and the use thereof | |
| MXPA02003360A (es) | Transacilasas de la ruta biosintetica de paclitaxel. | |
| WO2001048245A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| WO2001040521A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| ATE356212T1 (de) | O-fukosyltransferase | |
| WO2002103032A3 (en) | Catalases, nucleic acids encoding them and methods for making and using them | |
| WO2000029622A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |